Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
9
HYPD Quote, Financials, Valuation and Earnings
Last price:
$3.22
Seasonality move
:
-0.94%
Day range:
$3.20 - $3.50
52-week range:
$0.85 - $17.18
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
84.50x
P/B ratio:
0.37x
Volume:
214.2K
Avg. volume:
258.4K
1-year change:
-38.26%
Market cap:
$26.4M
Revenue:
$57.3K
EPS (TTM):
-$21.54
Analysts' Opinion
-
Consensus RatingHyperion DeFi, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $5.88, Hyperion DeFi, Inc. has an estimated upside of 80.22% from its current price of $3.26.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $4.00 representing 100% downside risk from its current price of $3.26.
Fair Value
-
According to the consensus of 2 analysts, Hyperion DeFi, Inc. has 80.22% upside to fair value with a price target of $5.88 per share.
HYPD vs. S&P 500
-
Over the past 5 trading days, Hyperion DeFi, Inc. has underperformed the S&P 500 by -0.84% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Hyperion DeFi, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Hyperion DeFi, Inc. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Hyperion DeFi, Inc. reported revenues of $302.5K.
Earnings Growth
-
Hyperion DeFi, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Hyperion DeFi, Inc. reported earnings per share of $0.05.
Enterprise value:
26.7M
EV / Invested capital:
--
Price / LTM sales:
84.50x
EV / EBIT:
--
EV / Revenue:
77.23x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-1.59x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$3.1M
Return On Assets:
-74.62%
Net Income Margin (TTM):
-7385.93%
Return On Equity:
-143.24%
Return On Invested Capital:
-90.16%
Operating Margin:
-881.16%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.2K | $31.8K | $345.3K | $1.6K | $302.5K | |
| Gross Profit | -$865.2K | -$1.8M | -$3.1M | -$419.9K | $302.5K | |
| Operating Income | -$23.3M | -$31.9M | -$22.3M | -$7.3M | -$2.7M | |
| EBITDA | -$22.4M | -$30.7M | -$22.1M | -$7M | -$2.8M | |
| Diluted EPS | -$0.67 | -$0.73 | -$21.54 | -$0.11 | $0.05 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $23.5M | $27.5M | $22.9M | $11.3M | $9.1M | |
| Total Assets | $25M | $31.4M | $34.9M | $22.8M | $82.8M | |
| Current Liabilities | $20.7M | $11M | $6.5M | $15.8M | $4M | |
| Total Liabilities | $20.7M | $11.1M | $19.1M | $19.1M | $12M | |
| Total Equity | $4.2M | $20.3M | $15.8M | $3.7M | $70.8M | |
| Total Debt | $7.3M | $7.2M | $15.5M | $12.4M | $8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$22.9M | -$30.3M | -$16.8M | -$5.9M | -$2.8M | |
| Cash From Investing | -$4.1M | -$306.7K | -$65.6M | -$1.6K | -$20.1M | |
| Cash From Financing | $22.5M | $17.1M | $83.5M | $10.8M | $23.6M | |
| Free Cash Flow | -$27.1M | -$30.6M | -$16.8M | -$5.9M | -$2.8M | |
HYPD
Sector
Market Cap
$26.4M
$26.2M
Price % of 52-Week High
18.98%
51.54%
Dividend Yield
0%
0%
Shareholder Yield
-124.38%
-1.64%
1-Year Price Total Return
-38.26%
-16.92%
Beta (5-Year)
2.689
0.489
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$3.41
200-day SMA
Sell
Level
$5.73
Bollinger Bands (100)
Sell
Level
3.61 - 9.17
Chaikin Money Flow
Buy
Level
31.4M
20-day SMA
Sell
Level
$3.51
Relative Strength Index (RSI14)
Sell
Level
42.14
ADX Line
Sell
Level
14.19
Williams %R
Buy
Level
-86.0516
50-day SMA
Sell
Level
$4.12
MACD (12, 26)
Sell
Level
-0.24
25-day Aroon Oscillator
Buy
Level
12
On Balance Volume
Neutral
Level
191.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-107.6391)
Sell
CA Score
(Annual)
Level (-12.4166)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (45.4634)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Hyperion DeFi, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in Laguna Hills, CA.
Stock Forecast FAQ
In the current month, HYPD has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HYPD average analyst price target in the past 3 months is $5.88.
-
Where Will Hyperion DeFi, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Hyperion DeFi, Inc. share price will rise to $5.88 per share over the next 12 months.
-
What Do Analysts Say About Hyperion DeFi, Inc.?
Analysts are divided on their view about Hyperion DeFi, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Hyperion DeFi, Inc. is a Sell and believe this share price will drop from its current level to $4.00.
-
What Is Hyperion DeFi, Inc.'s Price Target?
The price target for Hyperion DeFi, Inc. over the next 1-year time period is forecast to be $5.88 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HYPD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Hyperion DeFi, Inc. is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of HYPD?
You can purchase shares of Hyperion DeFi, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Hyperion DeFi, Inc. shares.
-
What Is The Hyperion DeFi, Inc. Share Price Today?
Hyperion DeFi, Inc. was last trading at $3.22 per share. This represents the most recent stock quote for Hyperion DeFi, Inc.. Yesterday, Hyperion DeFi, Inc. closed at $3.26 per share.
-
How To Buy Hyperion DeFi, Inc. Stock Online?
In order to purchase Hyperion DeFi, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get HYPD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HYPD
Sector
P/E ratio
--
23.89x
PEG ratio
0.00x
-0.01x
P/B ratio
0.37x
1.81x
Price / LTM sales
84.50x
1.59x
Growth Metrics
HYPD
Sector
Revenue growth
18515.75%
4.35%
Earnings growth
147.97%
9.8%
Revenue (5-year growth)
--
6.41%
Earnings forecast
--
-$0.18
Profitability
HYPD
Sector
Profitability FY 2024
-$5M
$3.2M
Return on invested capital
-90.16%
-32.76%
Return on assets
-74.62%
-29.32%
Return on equity
-143.24%
-38.6%
Earnings Date
Last Earnings Date
Nov
13
Next Earnings Date
Mar
31
Estimated Next Earnings Date
Feb
12
Balance Sheet
HYPD
Sector
Total cash
$8.2M
$25.4M
Short term investments
--
$25.1M
Total assets
$3.7M
$74.7M
Long term debt
$8M
$3.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
